Measuring Brain Health – MS On Your Mind Part 2

Featuring Augusto Miravalle, MD, FAAN This webinar is the second of a 2-part series titled, “MS On Your Mind.” MS expert neurologist Augusto Miravalle, MD provides knowledge regarding brain health and practical ways participants can apply this information in their shared decision-making with their care team. In this second part of the series, learn about […]

Read News Article

The Science of Brain Health – MS On Your Mind Part 1

Featuring Augusto Miravalle, MD, FAAN This webinar is the first of a 2-part series titled, “MS On Your Mind.” MS expert neurologist Augusto Miravalle, MD provides knowledge regarding brain health and practical ways people can apply this information in their shared decision-making with their care team. Those that live with multiple sclerosis, either diagnosed themselves […]

Read News Article

Ofatumumab

In this Update Main Article Introduction FDA-Approved Medications: Recently Approved New Data on Previously Approved Medications Experimental Medications New Directions in MS Research Closing Notes References Experimental Medications: Monoclonal Antibodies Company: Novartis and Genmab Injected subcutaneously, being studied at 20 mg monthly Being studied in RMS Previous: Plegridy® (peginterferon beta-1a) | Next: Ublituximab The Food and Drug Administration (FDA) is […]

Read News Article

Ocrevus® (ocrelizumab)

In this Update Main Article Introduction FDA-Approved Medications: Recently Approved New Data on Previously Approved Medications Experimental Medications New Directions in MS Research Closing Notes References FDA-Approved Medications: New Data on Previously Approved Medications: Infused Medications Company: Genentech and Roche Pharma AG Starting dose: 300 mg given via IV infusion, followed two weeks later by a […]

Read News Article

Vumerity® (diroximel fumarate)

In this Update Main Article Introduction FDA-Approved Medications: Recently Approved New Data on Previously Approved Medications Experimental Medications New Directions in MS Research Closing Notes References FDA-Approved Medications: Medications Recently Approved Company: Biogen Inc. and Alkermes plc Starting dose: 231 mg twice a day, orally, on Days 1-7 Maintenance dose after seven days: 462 mg (administered […]

Read News Article

Bafiertam™ (monomethyl fumarate)

In this Update Main Article Introduction FDA-Approved Medications: Recently Approved New Data on Previously Approved Medications Experimental Medications New Directions in MS Research Closing Notes References FDA-Approved Medications: Medications Recently Approved Company: Banner Life Sciences Starting dose: 95 mg twice a day, orally, for 7 days Maintenance dose after 7 days: 190 mg (administered as two […]

Read News Article

Opicinumab

In this Update Main Article Introduction FDA-Approved Medications: Recently Approved New Data on Previously Approved Medications Experimental Medications New Directions in MS Research Closing Notes References Experimental Medications: Monoclonal Antibodies Company: Biogen Given via IV infusion Being studied in RMS Previous: Ublituximab | Next: Rituxan® (rituximab) Researchers are investigating whether the monoclonal antibody opicinumab reverses neurologic damage and disability when […]

Read News Article